Mistletoe therapy has been shown to strengthen the immune system of cancer patients. it also improves their quality of life by relieving common side effects of conventional cancer therapies, reducing fatigue, and improving mood and thermoregulation. Mistletoe therapy supports patients in all phases of their disease. Therapy can start at any time, also to reduce recurrence rates and prevent recurrence.
Mistletoe therapy alleviates the most common side effects of one's oncological treatment.
- Improvement of persistent tiredness or exhaustion (fatigue)
- Normalization of sleep, temperature, appetite, and digestion
- Strengthening of the body's defences
- Increase of physical performance
Cancer treatment has fewer side effects if complementary measures are used in addition to conventional treatments such as surgery, chemotherapy, or radiotherapy. Mistletoe therapy is NOT a substitute for conventional cancer treatments.
Some ways that mistletoe therapy may help cancer patients are:
- Stimulating the immune system: Mistletoe has been found to stimulate the immune system by increasing the production of white blood cells and support blood counts during conventional treatments
- Diminish cancer-related pain and reduce the risk of tumour recurrence
- Reduce side effects of conventional treatments such as nausea, vomiting, lack of appetite, and low energy that may occur through chemotherapy or radiation
Four facts about mistletoe:
Mistletoe has been successfully used as concomitant cancer therapy since 1917.
The efficacy and very good tolerability of mistletoe therapy as concomitant cancer therapy has been demonstrated in more than 150 clinical trials with several of thee trials confirmed the positive effect, especially on the patients' quality of life.
Mistletoe is a complementary medicine which means that mistletoe therapy does not replace conventional medicine, but instead, it is a meaningful addition and extension. In all types of tumours, it improves patients' general condition and reduces the side effects of conventional measures.
Mistletoe therapy is recommended as concomitant therapy in every stage of cancer, as well as before, during, and after conventional therapy. Conventional therapies are usually better tolerated with simultaneous administration of mistletoe; healthy cells are protected from damage caused by cytostatic drugs. If cancer cannot be cured, mistletoe therapy helps patients live with a good quality of life.
Mistletoe therapy is the most frequently used concomitant therapy for cancer. Before, during, and after conventional treatment, it reduces symptoms and improves the patient's condition and general health.